from Reuters: Health News https://reut.rs/2Gan90g
GSK pays up to $4.2 billion for Merck KGaA cancer immunotherapy
GlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agreeing to pay up to 3.7 billion euros ($4.2 billion) to Germany's Merck KGaA for the rights to a next-generation immunotherapy.
from Reuters: Health News https://reut.rs/2Gan90g
from Reuters: Health News https://reut.rs/2Gan90g
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment